Infographic: Investment Opportunities in Biotech
Infographic: Investment Opportunities in Biotech
With the world evolving at an unprecedented pace, nearly every sector is being disrupted in some way or another.
In transportation, EVs were spearheaded by Tesla, which emerged as the first new American automaker in decades, and is now one of the world’s most valuable companies. Similarly, in the realm of AI, OpenAI has taken a leading position in large language models, demonstrating the immense potential of the technology.
Now, we turn our attention to biotech, an industry that is developing innovative treatments at an accelerated pace. In this graphic from sponsor MSCI, we explain the growing pipeline of biotech treatments, and why this could benefit investors.
Growth in Clinical Drug Trials
A clinical drug trial is a study performed on people to evaluate the effectiveness of a medical intervention. Since 2000, the number of trials initiated annually has grown by over 1,300%.
| Drug Trial Type | 2000 | 2010 | 2020 | 2022 |
|---|---|---|---|---|
| Monoclonal antibody | 60 | 623 | 1,833 | 1,685 |
| Protein & peptide therapeutics | 172 | 1,058 | 1,771 | 1,567 |
| Vaccine | 80 | 594 | 1,259 | 915 |
| Recombinant antibody | 50 | 513 | 984 | 860 |
| Cell therapy | 56 | 277 | 548 | 502 |
| Gene-Modified Cell Therapy | 16 | 148 | 355 | 423 |
| DNA & RNA therapeutics | 7 | 56 | 475 | 346 |
| Other biotechnology product | 28 | 236 | 362 | 347 |
| Total | 469 | 3,505 | 7,587 | 6,645 |
Behind every new treatment is an innovative company working to develop it. Thus, as the number of clinical trials grows, so too does the size of the investment universe.
Unfortunately, identifying suitable companies for investment is rather difficult. While a disease may have thousands of potential medicines, only one may ultimately receive FDA approval. This approval process can also take over a decade because treatments must pass several phases of testing.
Introducing the MSCI Life Sciences Indexes
To capture investment opportunities in biotech, MSCI has released a suite of thematic indexes that focus on key growth categories such as oncology and virology.
Developed in collaboration with Royalty Pharma, the world’s largest buyer of pharmaceutical royalties, the MSCI Life Sciences Indexes are designed to gauge the performance of pioneering companies within the biotech space.
These unique indexes can be used to benchmark growth, facilitate portfolio construction, and enhance investment research.
Explore the MSCI Life Sciences Indexes now
-
United States2 hours agoVisualizing the Most Common Pets in the U.S.
Lions, tigers, and bears, oh my!—these animals do not feature on this list of popular American household pets.
-
VC+5 days agoVC+: Get Our Key Takeaways From the IMF’s World Economic Outlook
A sneak preview of the exclusive VC+ Special Dispatch—your shortcut to understanding IMF’s World Economic Outlook report.
-
Lithium5 days agoRanked: The Top 10 EV Battery Manufacturers in 2023
Asia dominates this ranking of the world’s largest EV battery manufacturers in 2023.
-
Science7 days agoVisualizing the Average Lifespans of Mammals
While smaller animals such as weasels typically live 1-2 years, larger counterparts can thrive for decades.
-
Misc1 week agoHow Hard Is It to Get Into an Ivy League School?
We detail the admission rates and average annual cost for Ivy League schools, as well as the median SAT scores required to be accepted.
-
Maps2 weeks agoThe Largest Earthquakes in the New York Area (1970-2024)
The earthquake that shook buildings across New York in April 2024 was the third-largest quake in the Northeast U.S. over the past 50 years.
